Overview
- Study finds a higher incidence of suicidal ideation in patients using semaglutide, especially those with mental health conditions.
- Researchers analyzed data from over 28 million adverse drug reaction reports in a WHO database.
- The study highlights the need for cautious prescribing, particularly for patients with anxiety and depression.
- Experts urge more extensive research to understand the potential risks and mechanisms involved.
- Regulatory agencies in the US and Europe are reviewing safety data on GLP-1 receptor agonists.